English

CHEM RX CORP

EDGAR

Quarterly report (10-Q) · filed 2008-11-14

13 filing records in this dataset, filed from 2005-12-05 to 2008-11-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

89.9 million USD

2008-09-30 · USD

Exact inputs and evidence

Revenue: 89929000 USD Source

Operating margin

3.48%

2008-09-30 · %

Exact inputs and evidence

Operating Income: 3129000 USD Source
Revenue: 89929000 USD Source

Operating cash flow

2.98 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 12753000 USD Source
Operating Cash Flow: 9778000 USD Source

Free cash flow

2.4 million USD

2008-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: 12753000 USD Source
Operating Cash Flow: 9778000 USD Source
Capital Expenditure: 2647000 USD Source
Capital Expenditure: 2074000 USD Source

Cash and cash equivalents: 1.07 million USD 2008-09-30 Source
Exact value

1068000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-11-14.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2007-12-31
Operating income: 2 of 11 periods available· newest 2007-12-31
Net income: 2 of 11 periods available· newest 2007-12-31
Operating cash flow: 2 of 11 periods available· newest 2007-12-31
Capital expenditure: 2 of 11 periods available· newest 2007-12-31
Total assets: 2 of 11 periods available· newest 2007-12-31
Total liabilities: 2 of 11 periods available· newest 2007-12-31
Current assets: 2 of 11 periods available· newest 2007-12-31
Current liabilities: 2 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+USD 60.53 million

Prior period

USD 0

2006-01-01 – 2006-12-31
Current period

USD 60.53 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

60532143 − 0 = 60532143 USD

0 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
60532143 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CHEM RX CORP · 2007-12-31 CHEM RX CORP (edgar:1330487) Year-over-year change in Revenue: 60532143 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 60532143 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#5163 Input fundies:Revenue: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#5163
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 2.34 million

Prior period

−USD 16,677

2006-01-01 – 2006-12-31
Current period

USD 2.33 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

2326382 − -16677 = 2343059 USD

-16677 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
2326382 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CHEM RX CORP · 2007-12-31 CHEM RX CORP (edgar:1330487) Year-over-year change in Net income: 2343059 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 2326382 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#5883 Input fundies:NetIncome: -16677 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#5883
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-574.3%

Prior period

USD 878,699

2006-01-01 – 2006-12-31
Current period

−USD 4.17 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-4167330 − 878699 = -5046029 USD

878699 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-4167330 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CHEM RX CORP · 2007-12-31 CHEM RX CORP (edgar:1330487) Year-over-year change in Operating cash flow: -5046029 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -4167330 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6096 Input fundies:OperatingCashFlow: 878699 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6096
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+USD 762,464

Prior period

USD 0

2006-01-01 – 2006-12-31
Current period

USD 762,464

2007-01-01 – 2007-12-31

Exact inputs and evidence

762464 − 0 = 762464 USD

0 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
762464 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CHEM RX CORP · 2007-12-31 CHEM RX CORP (edgar:1330487) Year-over-year change in Capital expenditure: 762464 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 762464 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6163 Input fundies:CapitalExpenditure: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6163
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 60.53 million 100% of revenue
Operating costs Derived USD 57.66 million 95% of revenue
Operating income USD 2.87 million 4.7% of revenue
Tax, interest and other Derived USD 541,860 0.9% of revenue
Net income USD 2.33 million 3.8% of revenue

Cash

Operating cash flow −USD 4.17 million −6.9% of revenue
Capital expenditure USD 762,464 1.3% of revenue
Free cash flow Derived −USD 4.93 million −8.1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2006 Not shown: operating income or net income is not reported.
2007 95%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2006 2006-01-01 – 2006-12-31	0	2075737 Derived	-2075737	-2059060 Derived	-16677	878699 Derived	Source 2006-01-01 – 2006-12-31: 0 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -2075737 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -16677 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 878699 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 0 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	60532143	57663901 Derived	2868242	541860 Derived	2326382	-4929794 Derived	Source 2007-01-01 – 2007-12-31: 60532143 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 2868242 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 2326382 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -4167330 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 762464 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 60.5M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Revenue	0	Revenue: 0 Open source
20072007-12-31	Revenue	60532143	Revenue: 60532143 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Year over year	No prior comparable period	Revenue: 0 Open source
20072007-12-31	Year over year	No prior comparable period	Revenue: 60532143 Open source Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 4.7% 2007

Net margin 3.8% 2007

Free cash flow margin -8.1% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Operating margin	Not reported	Operating Income: -2075737 Open source Revenue: 0 Open source
20072007-12-31	Operating margin	4.7%	Operating Income: 2868242 Open source Revenue: 60532143 Open source
20062006-12-31	Net margin	Not reported	Net Income: -16677 Open source Revenue: 0 Open source
20072007-12-31	Net margin	3.8%	Net Income: 2326382 Open source Revenue: 60532143 Open source
20062006-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: 878699 Open source Capital Expenditure: 0 Open source
20072007-12-31	Free cash flow margin	-8.1%	Revenue: 60532143 Open source Operating Cash Flow: -4167330 Open source Capital Expenditure: 762464 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -4.2M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Operating cash flow	878699	Operating Cash Flow: 878699 Open source
20072007-12-31	Operating cash flow	-4167330	Operating Cash Flow: -4167330 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -4.9M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20062006-12-31	Free cash flow	878699	Operating Cash Flow: 878699 Open source Capital Expenditure: 0 Open source
20072007-12-31	Free cash flow	-4929794	Operating Cash Flow: -4167330 Open source Capital Expenditure: 762464 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

71.6% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Liabilities / assets	1.8%	Total Liabilities: 992688 Open source Total Assets: 54659599 Open source
20072007-12-31	Liabilities / assets	71.6%	Total Liabilities: 166972000 Open source Total Assets: 233044000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

3.24× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20062006-12-31	Current assets / current liabilities	0.19×	Current Assets: 189584 Open source Current Liabilities: 992688 Open source
20072007-12-31	Current assets / current liabilities	3.24×	Current Assets: 95694000 Open source Current Liabilities: 29564000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2006 2006-01-01 – 2006-12-31	−USD 16,677 Exact value Exact value: -16677 USD 2006-01-01 – 2006-12-31: -16677 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHEM RX CORP · 2006-12-31 CHEM RX CORP (edgar:1330487) Net Income: -16677 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16677 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#5883 The citation records this snapshot. The page link may show a newer release later.	USD 878,699 Exact value Exact value: 878699 USD 2006-01-01 – 2006-12-31: 878699 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHEM RX CORP · 2006-12-31 CHEM RX CORP (edgar:1330487) Operating Cash Flow: 878699 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 878699 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6096 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2006-01-01 – 2006-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHEM RX CORP · 2006-12-31 CHEM RX CORP (edgar:1330487) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6163 The citation records this snapshot. The page link may show a newer release later.	USD 878,699 Calculation and evidence 878699 − 0 USD Exact free cash flow: 878699 USD 2006-01-01 – 2006-12-31: 878699 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHEM RX CORP · 2006-12-31 CHEM RX CORP (edgar:1330487) Free cash flow: 878699 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 878699 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6096 Input fundies:CapitalExpenditure: 0 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6163 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	USD 2.33 million Exact value Exact value: 2326382 USD 2007-01-01 – 2007-12-31: 2326382 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHEM RX CORP · 2007-12-31 CHEM RX CORP (edgar:1330487) Net Income: 2326382 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2326382 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#5883 The citation records this snapshot. The page link may show a newer release later.	−USD 4.17 million Exact value Exact value: -4167330 USD 2007-01-01 – 2007-12-31: -4167330 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHEM RX CORP · 2007-12-31 CHEM RX CORP (edgar:1330487) Operating Cash Flow: -4167330 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4167330 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6096 The citation records this snapshot. The page link may show a newer release later.	USD 762,464 Exact value Exact value: 762464 USD 2007-01-01 – 2007-12-31: 762464 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHEM RX CORP · 2007-12-31 CHEM RX CORP (edgar:1330487) Capital Expenditure: 762464 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 762464 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6163 The citation records this snapshot. The page link may show a newer release later.	−USD 4.93 million Calculation and evidence -4167330 − 762464 USD Exact free cash flow: -4929794 USD 2007-01-01 – 2007-12-31: -4167330 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 762464 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHEM RX CORP · 2007-12-31 CHEM RX CORP (edgar:1330487) Free cash flow: -4929794 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-07T05:00:13Z Snapshot: 225db290493b2aa8f090dae63e3e5e9f1ffd167a26ffffac022a47bbde135954 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1330487?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -4167330 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6096 Input fundies:CapitalExpenditure: 762464 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1330487/0001047469-08-004171.txt#6163 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

13 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-07. Source filing dates and reporting periods are shown separately.

Identifiers: 0001330487, 1330487, edgar:1330487

Also known as Paramount Acquisition Corp

CHEM RX CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation